Pfizer (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) offer unique divergent investment opportunities in the pharmaceutical industry.
Keep Reading →
July 30 - News
Biotech M&A has hit a record pace in 2026, with deal value reaching $216 billion so far this year, up from $118 billion over the same stretch last year, according to LSEG data...
Keep Reading →
July 23 - News
The word “worst” here is not about business quality.
Keep Reading →
July 13 - Hedge Funds, News
In this article, we will look at the stocks Jim Cramer shared his opinions on during Mad Money.
Keep Reading →
July 9 - Hedge Funds, News
Dividend stocks can be tax-efficient, but only in a qualified sense.
Keep Reading →
July 7 - Hedge Funds, News
Expect strong market gains heading into the second half of the year.
Keep Reading →
July 3 - Dividend Stocks, Hedge Funds, News
Is PFE a good stock to buy? We came across a bullish thesis on Pfizer Inc. on r/ValueInvesting by Dismal-Cancel4958.
Keep Reading →
June 29 - News, Stock Analysis
On June 9, Reuters reported that Philips' Future Health Index survey concluded that artificial intelligence improved clinical accuracy and increased patient capacity.
Keep Reading →
June 27 - Hedge Funds, News
Dividend stocks remain a popular choice for income-focused investors.
Keep Reading →
June 24 - Dividend Stocks, Hedge Funds, News
On May 27, Reuters reported that Biohub, a philanthropic venture formed by Meta CEO Mark Zuckerberg and Dr.
Keep Reading →
June 22 - Hedge Funds, News
On June 8, Kim Iskyan, Director of Research at Tuttle Capital Management, appeared on BNN Bloomberg to discuss the outlook on the markets.
Keep Reading →
June 18 - Hedge Funds, News
The 2026 Fortune 500 rankings dropped earlier this month, and it showed that collectively, these companies pulled in $21 trillion in revenue, a 5% increase from last year, while...
Keep Reading →
June 13 - Dividend Stocks, Hedge Funds, News
Longevity stocks are getting more attention as investors look for companies tied to longer lifespans, healthier aging, and rising demand for care.
Keep Reading →
June 11 - Hedge Funds, News
TheFly reported on May 27 that PFE and Innovent Biologics announced a global strategic licensing and collaboration agreement covering the research and development of 12 early-...
Keep Reading →
June 2 - News
Haig Bathgate, CEO of Callanish Capital, stated on CNBC on May 7 that he is confident about global stocks despite worries over the Iran war.
Keep Reading →
May 31 - Hedge Funds, News
Pfizer Inc. (NYSE:PFE) ranks among the best retirement stocks to buy now. On May 5, BofA Securities boosted its price objective for Pfizer Inc.
Keep Reading →
May 27 - News
Pfizer Inc. (NYSE:PFE) is one of the best medical stocks to invest in according to billionaires. Pfizer Inc.
Keep Reading →
May 26 - News
A great many people struggle to determine how much money they will need to live comfortably in retirement, especially as retirement expenses rise annually.
Keep Reading →
May 25 - Hedge Funds, News
On May 20, Nancy Tengler of Laffer Tengler Investments appeared on CNBC to talk about the market reaction to economic conditions and how a likely pullback represents a good buying...
Keep Reading →
May 24 - Hedge Funds, News
On May 13, Vivek Arya from Bank of America Securities appeared on a CNBC Television interview.
Keep Reading →
May 21 - Hedge Funds, News
Dividends have played a bigger role in equity returns than most people realize.
Keep Reading →
May 15 - Dividend Stocks, Hedge Funds, News
In this article, we will look at the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up for this market.
Keep Reading →
May 13 - Hedge Funds, News
On May 4, Tom Lee, Fundstrat CIO & Head of Research, appeared on CNBC's 'Squawk Box' to discuss the latest market trends amidst ongoing geopolitical conflict.
Keep Reading →
May 8 - Hedge Funds, News
Operator: Good day, everyone, and welcome to Pfizer's First Quarter 2026 Earnings Conference Call. Today's call is being recorded.
Keep Reading →
May 6 - News, Transcripts
In this article, we will look at the stocks on Jim Cramer’s radar on Mad Money as he discussed the upcoming earnings.
Keep Reading →
May 4 - Hedge Funds, News
Pfizer Inc. (NYSE:PFE) ranks among the best low-risk investments in May 2026. On April 13, Guggenheim reaffirmed a Buy rating and a $36 price target for Pfizer Inc.
Keep Reading →
May 3 - News
On April 22, Tom Lee, Managing Partner and Head of Research at Fundstrat, spoke on CNBC Power Lunch and noted a favorable macro environment for stocks in 2026.
Keep Reading →
May 1 - Hedge Funds, News
According to a report by CMC Markets, research continues to show that stocks of innovative companies tend to outperform those of less innovative peers.
Keep Reading →
April 30 - Dividend Stocks, Hedge Funds, News
On April 28, Reuters reported that the US Food and Drug Administration has introduced a new pilot program that would allow the agency to monitor clinical trial data in real...
Keep Reading →
April 30 - Hedge Funds, Industries, News
On April 29, Joe Amato, Neuberger President and CIO, joined 'Squawk Box' to discuss the current state of the capital markets, noting that while there has been a significant snapback...
Keep Reading →
April 29 - Hedge Funds, News
Dividend growth stocks tend to offer a steady mix of earnings growth and reliable cash flow.
Keep Reading →
April 27 - Dividend Stocks, Hedge Funds, News
For a beginner entering the market in 2026, the term safe does not mean a stock can never go down.
Keep Reading →
April 22 - Hedge Funds, News
Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks for beginners to invest in. CICC initiated coverage of Pfizer Inc.
Keep Reading →
April 20 - News
On April 13, Jeremy Siegel, professor of finance at the Wharton School and chief economist at WisdomTree, appeared on CNBC’s 'Closing Bell' to discuss market resilience amid...
Keep Reading →
April 19 - Hedge Funds, News
Dividends have been part of the conversation for as long as modern finance has existed.
Keep Reading →
April 14 - Dividend Stocks, Hedge Funds, News
Cheap large-cap stocks are getting more attention as investors are looking past the market’s most crowded winners and are now putting more weight on the current entry points...
Keep Reading →
April 11 - Hedge Funds, News
Dividend stocks are getting more attention in the current market, and analysts still expect dividend growth to stay positive this year.
Keep Reading →
April 3 - Dividend Stocks, Hedge Funds, News
Large-cap stocks are usually issued by established companies with long track records. These are often well-known names that have been operating for years.
Keep Reading →
March 30 - Dividend Stocks, Hedge Funds, News
In this article, we will discuss: Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks.
Keep Reading →
March 29 - News
In this article, we will look at Jim Cramer’s breakdown of 16 stocks, including pharma plays for rising oil.
Keep Reading →
March 27 - Hedge Funds, News
Growth often takes center stage in an investing strategy. Still, for many investors, income can matter just as much, sometimes even more.
Keep Reading →
March 26 - Dividend Stocks, Hedge Funds, News
Pfizer Inc. (NYSE:PFE) is one of the best undervalued stocks under $50 to invest in now. Pfizer Inc.
Keep Reading →
March 25 - News
On March 20, Tom Lee, Fundstrat, appeared on CNBC's ‘Power Lunch’ to talk about his price target for the S&P and the potential of the market to rise higher.
Keep Reading →
March 24 - Hedge Funds, News
In this article, we will look at Jim Cramer’s stock calls as he discussed the bullish AI investment thesis amid the Iran conflict.
Keep Reading →
March 17 - Hedge Funds, News
Is PFE a good stock to buy now? We came across a bullish thesis on Pfizer Inc. on Investomine’s Substack. In this article, we will summarize the bulls’ thesis on PFE.
Keep Reading →
March 15 - News, Stock Analysis
Pfizer Inc. (NYSE:PFE) is one of Goldman Sachs top healthcare stocks. On March 9, analysts at BMO reiterated an Outperform rating on Pfizer Inc.
Keep Reading →
March 15 - News
The healthcare sector, long seen as a laggard amid the artificial intelligence boom, is beginning to turn the corner.
Keep Reading →
March 14 - Hedge Funds, News
On March 6, Reuters reported that China has approved Pfizer Inc. (NYSE:PFE)’s GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults.
Keep Reading →
March 12 - News
Dividend investors are often split between high yields and dividend growth. High dividend yields are sometimes viewed with suspicion.
Keep Reading →
March 11 - Dividend Stocks, Hedge Funds, News